OIG to Investigate HIX Flaws in 2014
The work plan specifies that "CMS relies extensively on contractors to help it carry out its basic mission, including administration, management, and oversight of its health programs…[but] Previous Government Accountability Office reports highlighted the vulnerabilities and weaknesses within the contracting environment at CMS.
Kusserow says that between the lines of the document, the issue revolves around the enormous amounts of money that the RACs deny on hospital claims, two-thirds of which are reversed when they get to the appeal level in front of the an administrative law judge.
Now, because of the backlog of claims on appeal, CMS has suspended assignment to ALJ hearings for at least 24 months, holding hospitals' claims funds in captivity. "The question is," he said, "what is the OIG doing about the problem? The appeals process is clogged, and what is (CMS) doing to streamline the process, so you don't have so many unmeritorious (RAC) contractor seizures" of hospital reimbursements?"
Questions About Contractors
Specific to the exchange rollout, 11 of the 60 new OIG projects involve the federal marketplaces—projects that were requested by HHS Secretary Kathleen Sebelius in a Dec. 10 letter to Inspector General Daniel Levinson.
She asked for reviews of the acquisition process for contracts to launch healthcare.gov, how contractors were selected, contract administration, "and the overall project management," and "whether contract specifications were met, and whether performance was adequately monitored.
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Top-Ranked MA Plans Earn Their Stars
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- Ebola: Health Officials Try to Quell Front Line Fears
- Defensive Medicine Still Prevalent Despite Tort Reform
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening
- How Hospitals Can Become 'Upstreamists'
- Partners HealthCare M&A Deal Under Scrutiny